News and Views

About Us

Main Conference Day One: Procurement Methods and Best Practices

Tuesday 19th March 2013

Key themes to be covered on the 19th March:

Delivering procurement best practice in a challenging macro-economic environment and changing healthcare market
Building efficient supplier relationship management models to generate supplier enabled innovation
How direct procurement teams can encourage suppliers to innovate for them to create a point of differentiation and competitive advantage
Reducing costs by achieving robust governance of the supply base and procurement methods
Strategic sourcing capabilities and procurement transformation in the biotechnology sector
Outsourcing of manufacturing – using a strategic partnership approach to create a global supply chain solution

07:15 Registration for invite only CPO breakfast briefing

No session description available.

08:30 General registration and coffee

No session description available.

09:10 Chair’s opening remarks

Trevor Jones, Director, Allergan Inc

No session description available.

Trevor Jones

Director, Allergan Inc

He is a visiting professor at King’s College, London and holds honorary degrees and Gold Medals from 6 universities. He is a founder member of the Geneva-based, Public: Private Partnership, Medicines for Malaria Venture (MMV) and in 2004 was appointed to the World Health Organisation (WHO) Commission on Intellectual Property Rights, Innovation and Public Health (C.I.P.I.H).He was for 12 years a me [read more]

09:20 KEYNOTE CASE STUDY ADDRESS: The road to supplier enabled innovation

Vasco Marcal Grilo, Vice President, Chief Procurement Officer, Janssen Pharmaceutical NV

Building an efficient Supplier Management model
How to become a customer of choice
Driving innovation throughout your organization
Capturing the value of innovation

Vasco Marcal Grilo

Vice President, Chief Procurement Officer, Janssen Pharmaceutical NV

Vasco heads up the EMEA Commercial Procurement function for the Pharmaceutical Group at Johnson & Johnson, leading a team of sourcing and procurement professionals positioned across the region. Under his leadership, the team is enabling the Pharmaceutical Group to succeed on the challenging goals of growth, simplification and val [read more]

09:50 PANEL DISCUSSION – THE BIG ISSUE: Practical strategies to deliver procurement best practice in a challenging macro-economic environment and changing healthcare market

Paula Gildert, Head of Development Strategic Sourcing, Novartis Pharma A.G.
Alejandro Basso, Corporate Purchasing Director, Almirall
Rajarshi Bhattacharya, VP - Practice Team, Genpact

Facing a shrinking blockbuster pipeline, patent cliffs and loss of exclusivity, combined with heavier government health budget cuts and post-regulation impacts on routes to market , what can procurement do to help companies grow in a time of stagnant growth?
Where is the next wave of opportunity to make savings? Where to find opportunity in the extended supply chain – both internally and externally?
Strategies to manage a procurement team in a stressed environment - how to balance the tactical versus strategic role of procurement?
How are healthcare companies having to change the way they’ve typically developed relationships with external partners to obtain different outcomes/ results
Successful partnerships - developing a common vision, goals and capabilities that deliver sustainable value for both parties

Paula Gildert

Head of Development Strategic Sourcing, Novartis Pharma A.G.

Paula is Head of Development Strategic Sourcing , Novartis Pharma, formerly Head R&D Procurement, AstraZeneca and is Fellow, Vice President, Board Member of the Chartered Institute of Purchasing and Supply. She is responsible for driving value in all external spend in the development of new medicines. A physicist & chartered control and electrical engineer with o [read more]

Alejandro Basso

Corporate Purchasing Director, Almirall

Alejandro is the Purchasing Corporate Director at Almirall, based in the company’s headquarters located in Barcelona. He has eighteen years experience in the pharmaceutical Industry and has always been linked to the Procurement function. He Joined Almirall in 2003, coming from a smaller Pharma company, starting as a International Purchasi [read more]

Rajarshi Bhattacharya

VP - Practice Team, Genpact

Raj has more than a decade of experience in the fields of Sourcing & SCM. He currently leads S2P Transformation engagements at Genpact. He led the structuring and commercializing Genpact’s proprietary Smart Enterprise Processes (SEP^SM) methodology in the Source To Pay space. Raj has implemented this framework to drive Source to Pay transfor [read more]

10:40 Morning coffee and networking

Speaker’s corner
During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly and candidly about any questions not covered during their session.

11:00 Managing change: Ten imperatives for future business success

Mitch Javidi, Adjunct Professor, North Carolina State University

The worldwide political, social, environmental, competitive, and economical landscape are affecting both bottom-lines and the future survival for business regardless of their sectors and markets. This is the case for Health Care Companies and is exemplified across procurement organizations undergoing transformations and seeking more strategic results from team members. This presentation will outline ten imperatives for effective change management to reach futuristic business outcomes and business longevity.

Mitch Javidi_North Carolina State University

Mitch Javidi

Adjunct Professor, North Carolina State University

Mitch Javidi, Ph.D. is an Adjunct Professor of MBA at North Carolina State University, and the CEO and President of NanoPhrades and Readiness Network. He is a forward-thinking scholar and professional recognized for change management and high-profile strategic and futuristic outcomes in Automotive, Banking, Chemical, Defense, Green, Government, Higher Education, Manufacturing, Pharmaceuticals, and [read more]

11:40 Strategic THINK TANK: CRO – Strategic supplier management

Melaye Ras-Work, Vice President, Efficio
Juraj Priecel, Vice President, Efficio

CROS are amongst the most critical suppliers but are often not strategically managed beyond ensuring they successfully execute studies. Procurement can play a critical role in supporting R&D to maximize the value from CRO relationships to speed time to market, innovate and better manage the cost of clinical studies. While the potential for improvement is significant, the challenges are no less important and need to be understood and addressed by procurement to not only “earn a seat at the table” but also help R&D better manage this strategic area of expenditure.

In this session we will discuss some of these challenges and allow participants to share experiences and approaches that have succeeded.

• What are the biggest challenges that procurement face in managing CROs? Why?
• How can these challenges be overcome?

Melaye Ras-Work

Vice President, Efficio

Melaye is a co-founder of Efficio, and has been with the firm since 2000. She has over 18 years of experience in industry and consulting, with a specific focus on strategic sourcing and supply chain optimisation. She has most recently led pan European client engagements for Financial Services, Pharmaceuticals, Manufacturing and Retail clients. Melaye is focused on growing Efficio's client base in [read more]

Juraj Priecel

Vice President, Efficio

Juraj is a co-founder of Efficio, and has been with the firm since 2000. He has over 20 years of experience in strategic sourcing, supply chain optimisation, operations consulting and organisational transformation. Juraj has recently managed engagements in the Telecoms, Pharmaceutical, Manufacturing, Chemical and Construction industries, and is an expert in the structuring and execution of large s [read more]

12:20 CASE STUDY: Driving procurement performance in healthcare

Juergen Schrapp, Head of Procurement Solutions, Bayer HealthCare

Bayer Healthcare is in the process of rolling out a 4 year strategy to become a world class Procurement organization.

Objectives and business case
Implementation approach
Lessons learned

Juergen Schrapp

Head of Procurement Solutions, Bayer HealthCare

Juergen Schrapp has been in Procurement for the past 15 years in various positions in Strategic Sourcing as well as in Tactical Procurement. He also gained several years of experience in the eProcurement environment at Hubwoo. Currently Juergen is part of the leadership team in Global Procurement at Bayer HealthCare and leading the Procurement Solutions Group there.

12:50 Structured "Speed" Networking

The best way to profile your peers by trading business cards, giving your elevator speech, then working the connections you’ve made until the moderator says it’s time to switch. Speed Networking is the best way to break the ice and make new contacts

13:15 Lunch and networking

Lunch and networking

Stream A: Direct Procurement Stream B: Indirect Procurement

14:15 Stream Chair: Opening remarks

Stream A: Direct Procurement

Paula Gildert, Head of Development Strategic Sourcing, Novartis Pharma A.G.

Stream Chair: Opening remarks

Paula Gildert

Head of Development Strategic Sourcing, Novartis Pharma A.G.

14:15 Stream Chair: Opening remarks

Stream B: Indirect Procurement

Trevor Jones, Director, Allergan Inc

Stream Chair: Opening remarks

Trevor Jones

Director, Allergan Inc

Stream A: Direct Procurement Stream B: Indirect Procurement

14:20 ROUNDTABLE SESSION: Outsourcing of manufacturing – using a strategic partnership approach to create a global supply chain solution

Stream A: Direct Procurement

Paula Gildert, Head of Development Strategic Sourcing, Novartis Pharma A.G.

• How to create a true partnership model rather than an outsourced service?
• How to truly collaborate to gain a global supply chain solution which achieves quality vs. cost return
• Where to gain the theoretical vs. tangible return – gain a return on the promises made
• Best practice for ‘excellence in execution’

Paula Gildert

Head of Development Strategic Sourcing, Novartis Pharma A.G.

14:20 CASE STUDY: Indirect procurement at Pfizer

Stream B: Indirect Procurement

Martin Dolezel, Senior Director Global Procurement, Europe, Middle East and Africa Lead, Pfizer

Procurement restructuring at Pfizer, team set up, how we operate, the issues we have faced and selected business cases

Martin Dolezel

Senior Director Global Procurement, Europe, Middle East and Africa Lead, Pfizer

Martin is responsible for the Global Procurement Operations (GPO) team in EMEA. The traditional mature markets (EU16) and Emerging Markets Europe (EME) were merged into one team in early 2011 and consolidated under Martin’s leadership. His role was then further extended in October 2012 to also include Africa and the Middle East. He holds full responsibility to deliver a functional procurement role [read more]

Stream A: Direct Procurement Stream B: Indirect Procurement

15:00 PANEL DISCUSSION: How can direct procurement teams encourage suppliers to innovate for them to create a point of differentiation and competitive advantage?

Stream A: Direct Procurement

David Harrison, Director, Manufacturing Alliances, UCB Celltech
Mark Hollison, Procurement Director, Napp Pharmaceuticals Ltd

• What departmental infrastructure should be in place so that innovation and supplier co-development takes place as the natural next step and not just ad-hoc ventures?
• How to enthuse and educate internal stakeholders (R&D) to co-develop with suppliers
• Innovation at the core of success - meeting the goal of delivering innovative medicines by identifying new ideas and new ways of working
• Best practice from direct procurement departments on aligning suppliers behind the innovation agenda
• How to use suppliers to innovate and create differentiating factors (eg. in packaging or medical devices) to gain a competitive advantage

David Harrison

Director, Manufacturing Alliances, UCB Celltech

Born in 1971 and attending The Lakes School, Cumbria, UKEducational background:Psychology Bsc (Hons) at the University of Leeds, UKPost-grad: CIPS (Chartered Institute of Purchasing & Supply)Work experience prior to UCB:Mobilis Healthcare (Senior Buyer – Consumer Retail & B2B)Abbott Laboratories (Supply Chain Specialist – Diabetes Care)Joined UCB: 01.11.2000 – Previ [read more]

Mark Hollison

Procurement Director, Napp Pharmaceuticals Ltd

Mark Hollison is Director of Procurement at Napp Pharmaceuticals Limited – A privately owned business which specialises in technology based medicines traditionally in the relief of moderate to severe pain but now diversifying into new therapeutic areas including those of oncology and respiratory disease. The role encompasses that of both ‘direct and indirect’ procurement activity and as part of th [read more]

15:00 Total cost-base management – the next step towards productivity excellence in healthcare

Stream B: Indirect Procurement

Sammy Rashed, AG and Executive Partner for Corporate Research, Institute for Supply Chain Management, Novartis

• Imperative to identify “what’s next” and why broadening Procurement's offering is the best option for growing its contribution, particularly in the Indirect Spend area
• Key differences between traditional approaches and comprehensively managing the company's spend
• Specific examples with demonstrated successes and lessons learned
• Codifying the journey into a repeatable process to optimize costs and drive organizational efficiency
The presentation is based on a research project from the European Business School, sponsored by Novartis.

Sammy Rashed

AG and Executive Partner for Corporate Research, Institute for Supply Chain Management, Novartis

Sammy Rashed has 20 years experience in senior management across various industries, and is currently Head of Productivity Strategy and PMO for Pharma, leading the strategy creation for building a world-class productivity organization and shared services model. Prior to this role Sammy was the Head of Strategy and Productivity for Pharma Global Sourcing. Since joining Novartis in 2001, he has head [read more]

Stream A: Direct Procurement Stream B: Indirect Procurement

15:30 Interactive roundtables: direct procurement

Stream A: Direct Procurement

Alejandro Basso, Corporate Purchasing Director, Almirall
David Harrison, Director, Manufacturing Alliances, UCB Celltech
Dan Quinn, Sector Development Director, Achilles

Hear how colleagues tackle problems similar to yours. In a small group and informal setting, these discussions provide a forum to share insight on current challenges.

Outsourcing (CMO/ CRO)

Should our preferred CMOs for commercial supply be involved during development? If so, what is the best time to involve them in order to capture maximum benefits, like innovation? If not, what are the main pitfalls, for example IP tie-ins, lack of competitive pressure or loss of agility?
Should we pay more for Quality and can you ever have enough (Quality)?

Consolidation of supply network

The healthcare environment is evolving towards personalized medicine and individual health outcomes. Does this mean an increasingly diverse supply network or can/should we still be able to consolidate and reduce the number of our partners?
Can CMOs ever be managed through a third party, where such party is not the MA holder? Are there any examples of where this runs smoothly and efficiently, or does the fact that the buck stops with the MA holder always get in the way?

Facilitated by: David Harrison, Director, Manufacturing Alliances, UCB

Supplier Management - A collaborative session discussing how the procurement & supply chain function is dealing with challenging issues facing the sector and how management of the supply chain is becoming a strategic lever to deliver significant and continual improvements

• What are the big picture issues currently facing your organisations procurement and supply functions?
• What actions are you taking to mitigate supply chain risk? What works in your organisation, and honestly what doesn’t?
• How clean, up to date and comprehensive is your vendor data? Is it an opportunity or a threat to your cost saving objectives?
• How efficient is your pre-qualification and due-diligence process? Do they systematically address risk and drive continual improvement?
• Does working collaboratively across the sector (in non-competitive areas) drive business benefits to all buyers and suppliers and facilitate greater public/regulator/NGO trust in the industry?
• How pan-sector collaboration can galvanise the supplier community to deliver significant improvements in data quality/visibility, minimise supply chain risk and drive supplier performance – and do this all at low cost

Facilitated by: Dan Quinn, Sector Development Director, Achilles

Risk management

Does your company has a formalized Risk Management Plan? It is supported by the top management?
Who is the owner of the risk management? Who is the Sponsor? Which are the areas involved and where it is reported?
Which general criteria are you using in your company to apply the risk management activities? A percentage of the company turnover? The top margin products? A percentage of your stock keeping units (SKU)? Other?
What risk mitigation levers are you using? Contracts? Alternative sources? Safety Stock? Others?
How often do you update your Risk Management Plan?
How do you monitor Supplier Risk?
Are you also including 2nd Tier suppliers follow up? In which cases?
Are you successful with your Risk Management? What are your challenges? what would you improve?

Facilitated by: Alejandro Basso, Corporate Purchasing Director, Almirall

Alejandro Basso

Corporate Purchasing Director, Almirall

David Harrison

Director, Manufacturing Alliances, UCB Celltech

Dan Quinn

Sector Development Director, Achilles

Dan Quinn is a Director with Achilles and is currently focussed on the Global Pharmaceutical sector, he is an MBA and experienced procurement professional with both direct and consulting experience across multiple sectors. Dan’s interests include linking Procurement/SCM to corporate strategy and the economic value added (or destroyed) in particular by supply chain and risk management activities. [read more]

15:30 Interactive roundtables: indirect procurement

Stream B: Indirect Procurement

Shervon Tham, Associate Director, Global Procurement - Capital and Engineering, Europe & Asia, Bristol-Myers Squibb
Ronald Schneijdenberg, Senior Category Manager - Indirect Sourcing EMEA, Medtronic
Dan Quinn, Sector Development Director, Achilles

Hear how colleagues tackle problems similar to yours. In a small group and informal setting, these discussions provide a forum to share insight on current challenges.

Change management

• With the procurement function evolving at each step towards “World Class”, how do you stimulate and manage this change within the organisation, external suppliers and within your team?
• What are the main challenges you face?
• Which are the key skills to manage successful change?
• Who are the Business partners in your organisation you will need to get support from? And what support do you need to make this change?

Facilitated by:Shervon Tham, Associate Director, Global Procurement - Capital and Engineering, Europe & Asia,Bristol-Myers Squibb

Supplier Management - A collaborative session discussing how the procurement & supply chain function is dealing with challenging issues facing the sector and how management of the supply chain is becoming a strategic lever to deliver significant and continual improvements

• What are the big picture issues currently facing your organisations procurement and supply functions?• What actions are you taking to mitigate supply chain risk? What works in your organisation, and honestly what doesn’t?
• How clean, up to date and comprehensive is your vendor data? Is it an opportunity or a threat to your cost saving objectives?
• How efficient is your pre-qualification and due-diligence process? Do they systematically address risk and drive continual improvement?
• Does working collaboratively across the sector (in non-competitive areas) drive business benefits to all buyers and suppliers and facilitate greater public/regulator/NGO trust in the industry?
• How pan-sector collaboration can galvanise the supplier community to deliver significant improvements in data quality/visibility, minimise supply chain risk and drive supplier performance – and do this all at low cost

Facilitated by: Dan Quinn, Sector Development Director, Achilles

Meetings & Events

• Who owns the Meetings & Events (M&E) process in your organization?
• Is your M&E process compliant with the Sunshine act and other regulatory requirements?
• Which tools and systems do you use to have full insight in the actual M&E spend?
• Which spend categories do you distinguish within M&E?
• What service levels/KPI’s do you have in place to track your suppliers’ performance?
• Do you believe it is possible to break the monopoly of congress organizers and book hotel-rooms directly with the hotels close to the congress location, against our own commercial conditions, instead of being forced to book hotels through the congress organization against inflated prices?

Facilitated by: Ronald Schneijdenberg, Senior Category Manager - Indirect Sourcing EMEA, Medtronic

Shervon Tham

Associate Director, Global Procurement - Capital and Engineering, Europe & Asia, Bristol-Myers Squibb

Ronald Schneijdenberg

Senior Category Manager - Indirect Sourcing EMEA, Medtronic

Feb. 2009-nowSenior category manager Indirect sourcing Medtronic EMEAScope: Leading category management for the EMEA indirect sourcing team at Medtronic. Responsible for a team of 4 category managers and app. EUR400M of purchasing revenue.2007-2009Supply Base Manager NXP (formerly Philips) SemiconductorsScope: Assisted in building up and co-managed the General Purchasing department after spin off [read more]

Dan Quinn

Sector Development Director, Achilles

16:15 Welcome drinks reception and networking

Welcome drinks reception and networking

	Content Partner	Sponsor	Sponsor	Exhibitor






	Interested In Sponsoring?
	Send me email updates






	Interested In Sponsoring?
	Send me email updates

Main Conference Day One: Procurement Methods and Best Practices

Tuesday 19th March 2013

Key themes to be covered on the 19th March:

Trevor Jones Director, Allergan Inc

Vasco Marcal Grilo Vice President, Chief Procurement Officer, Janssen Pharmaceutical NV

Paula Gildert Head of Development Strategic Sourcing, Novartis Pharma A.G.

Alejandro Basso Corporate Purchasing Director, Almirall

Rajarshi Bhattacharya VP - Practice Team, Genpact

Mitch Javidi Adjunct Professor, North Carolina State University

Melaye Ras-Work Vice President, Efficio

Juraj Priecel Vice President, Efficio

Juergen Schrapp Head of Procurement Solutions, Bayer HealthCare

Paula Gildert Head of Development Strategic Sourcing, Novartis Pharma A.G.

Trevor Jones Director, Allergan Inc

Paula Gildert Head of Development Strategic Sourcing, Novartis Pharma A.G.

Martin Dolezel Senior Director Global Procurement, Europe, Middle East and Africa Lead, Pfizer

David Harrison Director, Manufacturing Alliances, UCB Celltech

Mark Hollison Procurement Director, Napp Pharmaceuticals Ltd

Sammy Rashed AG and Executive Partner for Corporate Research, Institute for Supply Chain Management, Novartis

Alejandro Basso Corporate Purchasing Director, Almirall

David Harrison Director, Manufacturing Alliances, UCB Celltech

Dan Quinn Sector Development Director, Achilles

Shervon Tham Associate Director, Global Procurement - Capital and Engineering, Europe & Asia, Bristol-Myers Squibb

Ronald Schneijdenberg Senior Category Manager - Indirect Sourcing EMEA, Medtronic

Dan Quinn Sector Development Director, Achilles

Trevor Jones

Director, Allergan Inc

Vasco Marcal Grilo

Vice President, Chief Procurement Officer, Janssen Pharmaceutical NV

Paula Gildert

Head of Development Strategic Sourcing, Novartis Pharma A.G.

Alejandro Basso

Corporate Purchasing Director, Almirall

Rajarshi Bhattacharya

VP - Practice Team, Genpact

Mitch Javidi

Adjunct Professor, North Carolina State University

Melaye Ras-Work

Vice President, Efficio

Juraj Priecel

Vice President, Efficio

Juergen Schrapp

Head of Procurement Solutions, Bayer HealthCare

Paula Gildert

Head of Development Strategic Sourcing, Novartis Pharma A.G.

Trevor Jones

Director, Allergan Inc

Paula Gildert

Head of Development Strategic Sourcing, Novartis Pharma A.G.

Martin Dolezel

Senior Director Global Procurement, Europe, Middle East and Africa Lead, Pfizer

David Harrison

Director, Manufacturing Alliances, UCB Celltech

Mark Hollison

Procurement Director, Napp Pharmaceuticals Ltd

Sammy Rashed

AG and Executive Partner for Corporate Research, Institute for Supply Chain Management, Novartis

Alejandro Basso

Corporate Purchasing Director, Almirall

David Harrison

Director, Manufacturing Alliances, UCB Celltech

Dan Quinn

Sector Development Director, Achilles

Shervon Tham

Associate Director, Global Procurement - Capital and Engineering, Europe & Asia, Bristol-Myers Squibb

Ronald Schneijdenberg

Senior Category Manager - Indirect Sourcing EMEA, Medtronic

Dan Quinn

Sector Development Director, Achilles